Despite recent improvements, significant barriers remain for millions of Americans trying to afford GLP-1s. These drugs, known for their benefits, are still financially out of reach for many. Several patients have started exploring other options, often opting for cheaper but unregulated alternatives to get access to these medications.
This issue is part of the series, ‘GLP-1s: Reshaping America,’ reported by Stephanie Sy. She is a tenured journalist with PBS NewsHour. Her experience includes correspondent and anchor roles with ABC News, Al Jazeera America, and others. Before joining PBS NewsHour, she was with Yahoo News, providing coverage on significant events like the 2018 Midterm Elections and Donald Trump’s 2016 victory party.
The report also features Sam Lane and Mike Fritz. Sam Lane contributes to PBS NewsHour’s segment unit as a reporter and producer. Mike Fritz serves as the deputy senior producer for field segments at PBS NewsHour. Their combined efforts aim to highlight the ongoing struggles patients face with affordability and access.
Leave a Reply